Cited by

• Antibiotic therapy for pelvic inflammatory disease.

  Savaris RF, Fuhrich DG, Maissiat J, Duarte RV, Ross J. Savaris RF, et al. Cochrane Database Syst Rev. 2020 Aug 20;8(8):CD010285. doi: 10.1002/14651858.CD010285.pub3. Cochrane Database Syst Rev. 2020. PMID: 32820536 Free PMC article.
• Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.

  Tramont EC, Sadoff JC, Boslego JW, Ciak J, McChesney D, Brinton CC, Wood S, Takafuji E. Tramont EC, et al. J Clin Invest. 1981 Oct;68(4):881-8. doi: 10.1172/jci110343. J Clin Invest. 1981. PMID: 6116723 Free PMC article. Clinical Trial.
• Challenges and Controversies Concerning Neisseria gonorrhoeae-Neutrophil Interactions in Pathogenesis.

  Criss AK, Genco CA, Gray-Owen SD, Jerse AE, Seifert HS. Criss AK, et al. mBio. 2021 Jun 29;12(3):e0072121. doi: 10.1128/mBio.00721-21. Epub 2021 Jun 1. mBio. 2021. PMID: 34060328 Free PMC article.
• Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial.

  Cao C, Luo A, Wu P, Weng D, Zheng H, Wang S. Cao C, et al. Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1225-1230. doi: 10.1007/s10096-017-2913-z. Epub 2017 Mar 6. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28265816 Clinical Trial.
• ZY5301 Tablet vs Placebo for Treatment of Chronic Pelvic Pain After Pelvic Inflammatory Disease: A Phase 2 Randomized Clinical Trial.

  Teng X, Li H, Yang D, Gao Z, Cui L, Chen H, Song Q, Xu L, Li H, Zhang Q, Wu J, Leng J. Teng X, et al. JAMA Netw Open. 2024 Jul 1;7(7):e2423229. doi: 10.1001/jamanetworkopen.2024.23229. JAMA Netw Open. 2024. PMID: 39042407 Free PMC article. Clinical Trial.